Drug Approval | August 08, 2023
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
Syngene's collaboration with Zoetis started in 2011
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
Subscribe To Our Newsletter & Stay Updated
